APS Press RoomNews Highlights from The Journal of Pain October 2006
|
| For immediate release | Contact: Chuck Weber (847) 705-1802 |
Lance M. McCracken, Julian Hoskins and Christopher Eccleston
Royal National Hospital for Rheumatic Diseases, Bath, England
It’s widely known patients with chronic pain sometimes worry about taking medication. Some toxicology studies have shown about one third of patients with chronic non-cancer pain may be noncompliant with their prescription. This British study was designed to examine concerns of patients related to their use of pain medications. The authors surveyed 220 pain patients and assessed seven areas of patient concerns: addiction, perceived need, unfavorable scrutiny by others, adverse side effects, tolerance, mistrust in the prescribing doctor and withdrawal. Results from the multivariate analysis showed:
The authors also reported that distressed chronic pain patients said medication use was associated with further distress. Therefore, fears about treatment and its effects should be considered as a target of additional treatment for these patients.
Bert D. Stover, Judith A. Turner, Gary Franklin, Jeremy V. Glick, Deborah Fulton-Kehoe, Lianne Sheppard, Thomas M. Wickizer, Joel Kaufman and Kathleen Egan
University of Washington Environmental & Occupational Health Sciences
The authors studied 1067 workers in the state of Washington who filed workman’s compensation claims for low back injuries and had at least four days of work-related disability. Little is known about patient characteristics that may influence physicians’ decisions to prescribe opioids for acute back pain. This study is the first to examine factors associated with opioid prescriptions for acute work-related back pain.
The authors found that 35 percent of the injured workers received an opioid prescription at their first health care visit for the injury or during the next six weeks. This is contrary to current practice guidelines for treatment of low back pain that recommend NSAIDS and acetaminophen as first-line analgesics. For workers who received opioids later in the observation period, the authors concluded that persistence of pain led to the prescriptions.
In other findings:
The authors concluded their findings underscore the need for further research to examine racial and ethnic disparities in prescribing opioids and the reasons for high prescribing for tobacco users. Also, more research is needed to examine the impact of early opioid prescribing on long-term outcomes.
Dean A. Tripp, Queen’s University, Kingston Ontario
(There were 13 co-authors from multiple institutions)
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common and very painful urological syndrome with an estimated prevalence of 16 percent among North American males. Despite the proven benefits of psychosocial factors for adjusting to chronic pain, they have largely been ignored regarding CP/CPPS adjustment. The authors believe psychotherapies are given low priority in these patients because they are treated primarily by surgeons. The purpose of the study was to explore biopsychosocial factors predicting pain and disability in men with CP/CPPS.
In the study, catastrophizing, pain-contingent rest, solicitous responses, depression and urinary symptoms were hypothesized to have positive associations with CP/CPPS pain and disability, while perceived control over pain and social support would show negative associations.
The authors evaluated 253 men with CP/CPPS. They found that urinary symptoms, depression and catastrophizing made significant contributions to overall syndrome pain, and the resulting helplessness was a strong predictor of recurrent pain. Secondly, urinary symptoms, pain and pain-contingent rest were predictors of CP/CPPS disability. The authors noted that pain-contingent rest was the strongest predictor of disability. When patients avoid movement as a pain coping strategy, prolonged inactivity reduces mobility.
The study’s findings suggest that cognitive/behavioral variables are important predictors of pain and disability in men with CP/CPPS.